Syk Inhibitor Treats Rheumatoid Arthritis in Trial

Article

Syk Inhibitor R788 proven effective in treating rheumatoid arthritis.

Investigational Syk inhibitor R788 was proven effective in treating rheumatoid arthritis in a study by researchers from Brigham and Women’s Hospital and Harvard Medical School that was published in the New England Journal of Medicine.

The following video describes the study and discusses rheumatoid arthritis. Click here to access this third-party resource.

Related Videos
Deepak Sambhara, MD | Image Credit: American Society of Retina Specialists
David Brown, MD | Image Credit: Retina Consultants of Texas
Heart Failure stock imagery. | Credit: Fotolia
The HCPLive 5 | Image Credit: HCPLive
James Palmer, MD | Credit: Penn Medicine
© 2024 MJH Life Sciences

All rights reserved.